Prevalence of Diagnosed Atrial Fibrillation in Adults, JAMA, vol.285, issue.18, pp.285-2370, 2001. ,
DOI : 10.1001/jama.285.18.2370
En ligne] Disponible sur : http://ansm.sante.fr/var/ansm_site/storage/original/application ,
Evaluation de l'autosurveillance de l'INR chez les patients adultes traités par antivitamine K. [En ligne] Disponible sur : http://www.hassante.fr/portail ,
Evaluation of Trends of Inpatient Hospitalisation for Significant Haemorrhage in Patients Anticoagulated for Atrial Fibrillation before and after the Release of Novel Anticoagulants, Heart, Lung and Circulation, vol.24, issue.1, pp.24-94, 2015. ,
DOI : 10.1016/j.hlc.2014.06.013
Reservations against new oral anticoagulants after stroke and cerebral bleeding, Journal of the Neurological Sciences, vol.330, issue.1-2, pp.16-17, 2013. ,
DOI : 10.1016/j.jns.2013.03.017
Antidotes for Novel Oral Anticoagulants Current Status and Future Potential ,
Surdosage en AVK, situations à risque et accidents hémorragiques ? Recommandations. [En ligne] Disponible sur : http://www.hassante.fr/portail/jcms/c_682188/prise-en-charge-des-surdosages-des-situations-a-risque- hemorragique-et-desaccidents-hemorragiques-chez-les-patients-traites-par-antivitaminesk-en-ville-et-en-milieu-hospitalier ,
Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs, Thrombosis Journal, vol.12, issue.1, p.12, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.113.004747
Gestion périopératoire des anticoagulants oraux directs. [En ligne] Disponible sur : http://sofia.medicalistes.org/spip ,
Effective elimination of dabigatran by haemodialysis, Thrombosis and Haemostasis, vol.109, issue.4, pp.596-605 ,
DOI : 10.1160/TH12-08-0573
Reversal of novel oral anticoagulants in patients with major bleeding, Journal of Thrombosis and Thrombolysis, vol.109, issue.6, pp.35-391 ,
DOI : 10.1002/14651858.CD001886.pub4
Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management, Netherlands Journal of Medicine, issue.2, pp.68-68, 2010. ,
Bleeding and antidotes in new oral anticoagulants. Best Practice & Research Clinical Haematology, pp.191-202, 2013. ,
Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants, Canadian Journal of Cardiology, vol.29, issue.7, pp.29-34, 2013. ,
DOI : 10.1016/j.cjca.2013.04.013
New anticoagulants: how to deal with treatment failure and bleeding complications, British Journal of Clinical Pharmacology, vol.62, issue.2, pp.593-603, 2011. ,
DOI : 10.1111/j.1365-2044.2007.05195.x
Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents, Journal of Thrombosis and Thrombolysis, vol.35, issue.3, pp.39-395 ,
DOI : 10.1007/s11239-013-0885-0
Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates, BioMed Research International, vol.116, issue.183, p.2014 ,
DOI : 10.1177/1076029613494468
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects, Circulation, vol.124, issue.14, pp.124-1573, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.029017
Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis, Journal of Neurology, vol.33, issue.2104 ,
DOI : 10.1002/phar.1269
Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated, Stroke, vol.40, issue.1 ,
DOI : 10.1161/STROKEAHA.108.516344
Fibrillation auriculaire. [En ligne] Disponible sur : http://www.hugge .ch/sites/interhug/files/structures/medecine_de_premier_recours/documents, 2015. ,
Guidelines for the management of atrial fibrillation, European heart journal, issue.19, pp.31-2369, 2010. ,
Outcome parameters for trials in atrial fibrillation ,
Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment, Public Library of Science one, vol.10, issue.4, 2015. ,
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF), American Heart Journal, vol.151, issue.3 ,
DOI : 10.1016/j.ahj.2005.04.017
Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk???Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation, Journal of the American College of Cardiology, vol.60, issue.9, pp.60-861 ,
DOI : 10.1016/j.jacc.2012.06.019
et al The net clinical benefit of warfarin anticoagulation in atrial fibrillation, Annals of internal medicine, issue.5, pp.151-297, 2009. ,
et al Anticoagulation de la fibrillation atriale par les nouveaux anticoagulants chez la personne âgée : les limites de « l'Evidence-Based Medicine ,
Rapport sur les anticoagulants oraux directs (AOD). [En ligne] Disponible sur : http://www.academie-medecine, 2014. ,
Dabigatran versus Warfarin in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.361, issue.12 ,
DOI : 10.1056/NEJMoa0905561
Novel oral anticoagulants in gastroenterology practice, Gastrointestinal Endoscopy, vol.78, issue.2, pp.78-227, 2013. ,
DOI : 10.1016/j.gie.2013.04.179
Dabigatran Association With Higher Risk of Acute Coronary Events, Archives of Internal Medicine, vol.172, issue.5, pp.172-397, 2012. ,
DOI : 10.1001/archinternmed.2011.1666
Bleeding Risk with Dabigatran in the Frail Elderly, New England Journal of Medicine, vol.366, issue.9 ,
DOI : 10.1056/NEJMc1112874
Prise en charge de la fibrillation auriculaire : recommandations ESC 2010 et 2012. [En ligne] Disponible sur ,
Minor bleeds alert for subsequent major bleeding in patients using vitamin K antagonists, British Journal of Haematology, vol.24, issue.4, pp.508-514, 2011. ,
DOI : 10.1592/phco.24.14.1311.43144
URL : https://hal.archives-ouvertes.fr/hal-00625169
focused update of the ESC Guidelines for the management of atrial fibrillation, European heart journal, issue.21, pp.33-2719, 2012. ,
Accidents to AVK: a retrospective study of 30 cases, Pan African medical journal, issue.11, p.24, 2011. ,
New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis, Gastroenterology, vol.145, issue.1 ,
DOI : 10.1053/j.gastro.2013.02.041
On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage, Journal of Gastrointestinal and Liver Diseases, vol.22, pp.229-231, 2013. ,
Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions, Stroke, vol.37, issue.1 ,
DOI : 10.1161/01.STR.0000196989.09900.f8
URL : http://stroke.ahajournals.org/content/strokeaha/37/1/256.full.pdf
Outcome following intracranial hemorrhage associated with novel oral anticoagulants, Journal of Clinical Neuroscience, vol.22, issue.1, pp.212-215, 2015. ,
DOI : 10.1016/j.jocn.2014.04.025
Characteristics of Intracerebral Hemorrhage During Rivaroxaban Treatment Comparison With Those During Warfarin ,
Spine subdural hematoma: a rare complication associated with vitamin K antagonist (VKA) ,
Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale ,
Management of gastrointestinal bleeding in patients anticoagulated with dabigatran compared with warfarin: a retrospective, comparative case review. Cardiovascular diagnosis and therapy, p.224 ,
Management of major bleeding complications and emergency surgery in patients on longterm treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis, Archives of cardiovascular diseases, issue.6, pp.106-382, 2013. ,
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban, Thrombosis and Haemostasis, vol.108, issue.2, pp.217-224 ,
DOI : 10.1160/TH12-03-0179
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials, The Lancet, vol.383, issue.9921, pp.383-955, 2014. ,
DOI : 10.1016/S0140-6736(13)62343-0
URL : https://hal.archives-ouvertes.fr/hal-00935589
Étude " en vie réelle du bénéfice/risque à court terme des nouveaux anticoagulants oraux (dabigatran, rivaroxaban) chez les patients débutant un traitement et non précédemment traités par des antivitamines K Étude NACORA-BR du projet NACORA (nouveaux anticoagulants oraux et risques associés) [En ligne] Disponible sur : http://ansm.sante.fr/content/download Bleeding complications related to warfarin treatment: a descriptive register study from the anticoagulation clinic at Helsingborg Hospital, Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés (CNAMTS), pp.38-98, 828917. ,
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups, Thrombosis, vol.126, issue.19, p.2013 ,
DOI : 10.1016/S0140-6736(11)61294-4
Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials, European Journal of Vascular and Endovascular Surgery, vol.48, issue.5, pp.565-575 ,
DOI : 10.1016/j.ejvs.2014.05.001
Meta-analysis of randomized controlled trials on the risk of bleeding with dabigatran Dabigatran and warfarin in vitamin K antagonist?naive and?experienced cohorts with atrial fibrillation, American journal of cardiology Circulation, vol.113, issue.622, pp.1066-1074, 2010. ,
Safety of new oral anticoagulant drugs: a perspective. Therapeutic advances in drug safety, pp.8-20, 2013. ,
Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for non-valvular atrial fibrillation, Circulation, issue.2, pp.131-157, 2014. ,
Efficacy and Safety of Dabigatran Etexilate and Warfarin in ???Real-World??? Patients With Atrial Fibrillation, Journal of the American College of Cardiology, vol.61, issue.22, pp.61-2264, 2013. ,
DOI : 10.1016/j.jacc.2013.03.020